Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where D Bendayan is active.

Publication


Featured researches published by D Bendayan.


Respiration | 2008

Absence of Human Herpesvirus 8 DNA Sequences in Lung Biopsies from Israeli Patients with Pulmonary Arterial Hypertension

D Bendayan; R. Sarid; A. Cohen; David Shitrit; I. Shechtman; Mordechai R. Kramer

Background:Pulmonary hypertension is a severe pulmonary vascular disease leading to rapid deterioration and death. Histological and clinical evidence suggests that smooth muscle proliferation is part of the pathogenesis of the disease. Human herpesvirus 8 (HHV-8) is a γ-herpesvirus that is implicated in malignancies and in Kaposi’s sarcoma. Recently, the association of HHV-8 with idiopathic pulmonary arterial hypertension (PAH) has been found. Objective: The aim of this study was to investigate the presence of HHV-8 in the lung tissue of Israeli patients with PAH. Method: The presence of HHV-8 sequences was investigated by polymerase chain reaction examination in 6 biopsies of patients with pulmonary hypertension. Three patients had idiopathic pulmonary hypertension, 2 patients pulmonary venoocclusive disease, and 1 patient pulmonary hypertension associated with mixed connective tissue disease. Result: We did not find any association between HHV-8 and PAH in these Israeli patients, as all the samples were negative for polymerase chain reaction. Conclusion: Our findings, together with the epidemiological data of HHV-8 prevalence and incidence rates of Kaposi’s sarcoma and PAH in Israel, provide further evidence which argues against an association between HHV-8 infection and PAH.


Respiration | 2002

Elevation of ELISA D-Dimer Levels in Patients with Primary Pulmonary Hypertension

David Shitrit; D Bendayan; B. Rudensky; Gabriel Izbicki; Michael Huerta; Gershon Fink; Mordechai R. Kramer

Background: Vasoconstriction, vascular wall remodeling and thrombosis are considered as possible etiologies of primary pulmonary hypertension (PPH). D-dimer, a degradation product of fibrin, has been increasingly used as a marker and prognostic factor in various diseases. Objective: To assess elevated ELISA D-dimer levels as a marker of endogenous fibrinolysis in patients with PPH. Patients and Methods: Comparison of ELISA D-dimer levels of 12 PPH patients (11 female, 1 male) aged 27–73 years (median 51 years) with those of sex- and age-matched healthy controls. Results: Eleven patients had New York Heart Association (NYHA) class III or IV symptoms, and one patient had NYHA class II symptoms. All patients with PPH were treated with anticoagulants and vasodilators: 5 patients were treated with continuous intravenous prostacyclin, 4 patients with continuous UT-15 and 2 patients with intermittent intravenous iloprost. Mean ELISA D-dimer levels ± SD were significantly higher in the PPH group than in the matched control group (473 ± 109 vs. 182 ± 103 ng/ml; mean difference: 291 ± 79, 95% CI: 240–341, p < 0.0001). Conclusion: These results suggest the possible involvement of endogenous fibrinolysis in the pathophysiology of PPH.


Transplantation Proceedings | 2003

The role of fiberoptic bronchoscopy evaluating transplant recipients with suspected pulmonary infections: analysis of 168 cases in a multi-organ transplantation center

Daniel Starobin; Gershon Fink; David Shitrit; Gabriel Izbicki; D Bendayan; Ilana Bakal; Mordechai R. Kramer

ULMONARY INFECTIOUS complications are common in patients after solid organ transplantation (SOT) or bone marrow transplantation (BMT) and are responsible for significant morbidity and mortality. Early diagnosis of infectious complications is extremely important for the outcome of transplant recipients 1‐3 The purpose of this study was to examine the role of fiberoptic bronchoscopy (FOB) in transplant recipients with suspected pulmonary infections. METHODS The study was conducted at the Institute of Pulmonary Medicine. Rabin Medical Center, Beilinson Campus (a tertiary-care university hospital). We retrospectively examined data of patients posttransplantation who required FOB from May 5, 1999 until May 2002. Indications for FOB were suspected pulmonary infection by either abnormal chest X-ray or respiratory symptoms. Lung transplant recipients with surveillance bronchoscopies were excluded from the study. Patients underwent bronchoalveolar lavage (BAL); specimens were analyzed as bacteriology, virology, fungal, and mycobacterial cultures. In 65% of cases, transbronchial biopsies (TBBs) were done; specimens were sent to pathological examination as well as silver and cytomegalovirus (CMV)-specific stains.


Respiratory Medicine | 2000

Pulmonary calcifications: a review

D Bendayan; Y. Barziv; Mordechai R. Kramer


Chest | 2006

Is routine chest radiography after transbronchial biopsy necessary? A prospective study of 350 cases

Gabriel Izbicki; David Shitrit; Alex Yarmolovsky; D Bendayan; Galit Miller; Gershon Fink; Asher Mazar; Mordechai R. Kramer


Respiratory Medicine | 2003

Hyperuricemia as a prognostic factor in pulmonary arterial hypertension

D Bendayan; David Shitrit; M Ygla; Michael Huerta; Gershon Fink; Mordechai R. Kramer


Respiratory Medicine | 2009

The prevalence of coronary artery disease in end-stage pulmonary disease: Is pulmonary fibrosis a risk factor?

Gabriel Izbicki; Itsik Ben-Dor; David Shitrit; D Bendayan; Thomas K. Aldrich; Ran Kornowski; Mordechai R. Kramer


Journal of Heart and Lung Transplantation | 2005

Recurrence of Pulmonary Veno-occlusive Disease After Heart-Lung Transplantation

Gabriel Izbicki; David Shitrit; Itzhak Schechtman; D Bendayan; Gershon Fink; Gideon Sahar; Milton Saute; Tuvia Ben-Gal; Mordechai R. Kramer


Thorax | 2004

Multidrug resistant tuberculosis following lung transplantation: treatment with pulmonary resection

David Shitrit; D Bendayan; Milton Saute; Mordechai R. Kramer


Thorax | 2007

A “fat chance” it’s malignant: lipoid pneumonia simulating lung cancer on PET scan

Ben Fox; I. Shechtman; David Shitrit; D Bendayan; Mordechai R. Kramer

Collaboration


Dive into the D Bendayan's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gabriel Izbicki

Shaare Zedek Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A Kogan

Rabin Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael Huerta

Shaare Zedek Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge